Form 4: Zimmer Biomet Executive Sang Yi Reports Stock Transactions
SEC Form 4
Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and the sale of shares.
Summary
- On March 6, 2024, Sang Yi vested 2,365 restricted stock units (RSUs) which converted into common stock.
- On March 7, 2024, Yi exercised an option to purchase 1,705 shares at $91.53 and sold 1,705 shares at $126.86.
- Following these transactions, Yi directly owns 18,179 shares of Zimmer Biomet Holdings, Inc. common stock.
- Yi also directly owns 4,729 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Restricted stock units vested |
| 03/07/2024 | Shares acquired through option exercise and sold |
| 03/07/2024 | Form 4 filing date |
| 03/06/2025 | One-half of remaining RSUs vest |
| 03/06/2026 | One-half of remaining RSUs vest |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.